Novorapid and hepatic function abnormal 
Novorapid and hepatic function abnormal Patient Reports February 10, 2010
Novorapid Side Effects Report #5719408-7
Novorapid side effect was reported by a Physician from JAPAN on Apr 17, 2008. Female patient, 68 years of age, weighting 88.18 lb, was diagnosed with type 2 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cerebral haemorrhage traumatic, hepatic function abnormal. Novorapid dosage: unknown. During the same period patient was treated with LANTUS, BASEN, MEVALOTIN, BLADDERON. Patient was hospitalized. Patient recovered.
Novorapid Side Effects Report #5683834-5
Novorapid side effect was reported by a Physician from JAPAN on Mar 17, 2008. Male patient, 67 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: hepatic function abnormal, stomach discomfort. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN N, GASMOTIN, NOVORAPID CHU, EUGLUCON, DAONIL. Patient was hospitalized. Patient recovered.
Novorapid Side Effects Report #5696143-5
Novorapid side effect was reported by a Physician from JAPAN on Mar 25, 2008. Male patient, weighting 138.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: hepatic function abnormal. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN N, GASMOTIN, NOVORAPID CHU, NOVORAPID CHU, EUGLUCON, DAONIL, ASPIRIN, LEVEMIR. Patient was hospitalized. Patient recovered.
Novorapid Side Effects Report #5712773-6
Novorapid side effect was reported by a Physician from JAPAN on Apr 11, 2008. Male patient, weighting 138.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN N, GASMOTIN, NOVORAPID CHU, NOVORAPID CHU, EUGLUCON, DAONIL, ASPIRIN, LEVEMIR. Patient was hospitalized. Patient recovered.
Novorapid Side Effects Report #5725314-4
Novorapid side effect was reported by a Physician from JAPAN on Apr 22, 2008. Male patient, weighting 138.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: hepatic function abnormal. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN N, GASMOTIN, NOVORAPID CHU, NOVORAPID CHU, EUGLUCON, DAONIL, ASPIRIN, LEVEMIR. Patient was hospitalized. Patient recovered.
Novorapid Side Effects Report #5729263-7
Novorapid side effect was reported by a Physician from JAPAN on Apr 25, 2008. Female patient, weighting 85.98 lb, was diagnosed with type 2 diabetes mellitus, hyperlipidaemia, pollakiuria, neurogenic bladder and was treated with Novorapid. After drug was administered, patient experienced the following side effects: hepatic function abnormal. Novorapid dosage: unknown. During the same period patient was treated with LANTUS, BASEN, MEVALOTIN, BLADDERON, AMARYL. Patient was hospitalized. Patient recovered.
Novorapid Side Effects Report #5742473-8
Novorapid side effect was reported by a Physician from JAPAN on May 08, 2008. Female patient, weighting 85.98 lb, was diagnosed with type 2 diabetes mellitus, hyperlipidaemia, pollakiuria, neurogenic bladder and was treated with Novorapid. After drug was administered, patient experienced the following side effects: hepatic function abnormal. Novorapid dosage: unknown. During the same period patient was treated with LANTUS, BASEN, MEVALOTIN, BLADDERON, AMARYL. Patient was hospitalized. Patient recovered.
Novorapid Side Effects Report #5570586-2
Novorapid side effect was reported by a Pharmacist from JAPAN on Dec 11, 2007. Female patient, 16 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: hepatic function abnormal. Novorapid dosage: unknown. During the same period patient was treated with LANTUS. Patient recovered.
Novorapid Side Effects Report #5576106-0
Novorapid side effect was reported by a Pharmacist from JAPAN on Dec 21, 2007. Female patient was diagnosed with type 1 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: hepatic function abnormal. Novorapid dosage: unknown. During the same period patient was treated with LANTUS. Patient was hospitalized. Patient recovered.
Novorapid Side Effects Report #5583893-4
Novorapid side effect was reported by a Pharmacist from JAPAN on Dec 28, 2007. Female patient was diagnosed with type 1 diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: hepatic function abnormal. Novorapid dosage: unknown. During the same period patient was treated with LANTUS. Patient was hospitalized. Patient recovered.
Novorapid Side Effects Report #5364891-2
Novorapid side effect was reported by a Physician from JAPAN on June 12, 2007. Male patient, 75 years of age, weighting 132.3 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: hepatic function abnormal. Novorapid dosage: unknown. During the same period patient was treated with DAONIL, METFORMIN, BASEN, ADALAT, MICARDIS, ZYLORIC, ZANTAC. Patient recovered.
Novorapid Side Effects Report #5374473-4
Novorapid side effect was reported by a Physician from JAPAN on June 22, 2007. Male patient, weighting 132.3 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, hypertension, hyperuricaemia and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic function abnormal. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN, DAONIL, MELBIN, BASEN, ADALAT, MICARDIS, ZYLORIC, ZANTAC. Patient recovered.
Novorapid Side Effects Report #5379938-7
Novorapid side effect was reported by a Physician from JAPAN on June 28, 2007. Male patient, weighting 132.3 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, hypertension, hyperuricaemia and was treated with Novorapid. After drug was administered, patient experienced the following side effects: dilatation intrahepatic duct acquired, hepatic function abnormal, hepatitis
, malaise. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN, DAONIL, MELBIN, BASEN, ADALAT, MICARDIS, ZYLORIC, ZANTAC. Patient recovered.Novorapid Side Effects Report #5389949-3
Novorapid side effect was reported by a Physician from JAPAN on July 06, 2007. Male patient, weighting 132.3 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, hypertension, hyperuricaemia and was treated with Novorapid. After drug was administered, patient experienced the following side effects: dilatation intrahepatic duct acquired, hepatic function abnormal, hepatitis
, malaise. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN, DAONIL, MELBIN, BASEN, ADALAT, MICARDIS, ZYLORIC, ZANTAC. Patient recovered.Novorapid Side Effects Report #5507407-X
Novorapid side effect was reported by a Physician from JAPAN on Oct 26, 2007. Female patient, weighting 103.6 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, hyperlipidaemia, cerebral infarction, hypertension and was treated with Novorapid. After drug was administered, patient experienced the following side effects: hepatic function abnormal, hypoglycaemia. Novorapid dosage: unknown. During the same period patient was treated with NOVORAPID CHU, NOVOLIN N, LIPITOR, ASPIRIN, TANATRIL, ADALAT. Patient was hospitalized. Patient recovered.
Novorapid Side Effects Report #5832216-1
Novorapid side effect was reported by a Physician from JAPAN on July 25, 2008. Female patient, weighting 103.6 lb, was diagnosed with insulin-requiring type 2 diabetes mellitus, hyperlipidaemia, cerebral infarction, hypertension and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, hepatic function abnormal, hypoglycaemia. Novorapid dosage: unknown. During the same period patient was treated with NOVORAPID CHU, NOVOLIN N, LIPITOR, BAYASPIRIN, TANATRIL, ADALAT. Patient was hospitalized. Patient recovered.
Novorapid Side Effects Report #4980197-5
Novorapid side effect was reported by a Physician from JAPAN on Oct 16, 2003. Female patient, 29 years of age, was diagnosed with diabetes mellitus insulin-dependent and was treated with Novorapid. After drug was administered, patient experienced the following side effects: acne
, cholecystitis acute, diabetic ketoacidosis, erythema, hepatic function abnormal, oedema peripheral. Novorapid dosage: unknown. During the same period patient was treated with NOVORAPID CHU FLEXPEN, NOVOLIN N, NOVOLIN N, HUMULIN, NOVOLIN R. Patient was hospitalized. Patient recovered.Novorapid Side Effects Report #4733239-6
Novorapid side effect was reported by a Physician from JAPAN on July 07, 2005. Male patient, 28 years of age, weighting 125.7 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, chest discomfort, hepatic function abnormal, thirst. Novorapid dosage: unknown. Patient was hospitalized. Patient recovered.
Novorapid Side Effects Report #4700118-X
Novorapid side effect was reported by a Physician from on Nov 26, 2004. Male patient, 77 years of age, was diagnosed with diabetes mellitus, ill-defined disorder and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatic function abnormal. Novorapid dosage: unknown. During the same period patient was treated with NOVOLOG, FLUTRIA, RENIVACE, KINEDAK. Patient was hospitalized. Patient recovered.
Novorapid Side Effects Report #5246689-9
Novorapid side effect was reported by a Physician from JAPAN on Feb 14, 2007. Male patient, 74 years of age, was diagnosed with diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: hepatic function abnormal. Novorapid dosage: unknown. During the same period patient was treated with ODRIC, LIPITOR. Patient recovered.
Novorapid Side Effects Report #4552837-6
Novorapid side effect was reported by a Physician from on Dec 01, 2004. Female patient, 66 years of age, weighting 85.98 lb, was diagnosed with diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal, hepatomegaly. Novorapid dosage: unknown. Patient was hospitalized. Patient recovered.
Novorapid Side Effects Report #5347517-3
Novorapid side effect was reported by a Physician from JAPAN on May 25, 2007. Female patient, 55 years of age, was diagnosed with diabetes mellitus, hyperlipidaemia, diabetic neuropathy, insomnia, constipation
and was treated with Novorapid. After drug was administered, patient experienced the following side effects: hepatic function abnormal. Novorapid dosage: unknown. During the same period patient was treated with LANTUS, MEVALOTIN, KINEDAK, CYANOCOBALAMIN, LENDORMIN, ALOSENN, HUMALOG. Patient was hospitalized. Patient recovered.Novorapid Side Effects Report #4597690-X
Novorapid side effect was reported by a Physician from on Dec 24, 2004. Female patient, 55 years of age, weighting 97.00 lb, was diagnosed with diabetes mellitus, ill-defined disorder and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, glycosylated haemoglobin increased, hepatic function abnormal, hepatomegaly. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN N, RABEPRAZOLE, PRIMPERAN, HUMULIN. Patient was hospitalized. Patient recovered.
Novorapid Side Effects Report #4617244-6
Novorapid side effect was reported by a Physician from on Dec 24, 2004. Female patient, 55 years of age, weighting 97.00 lb, was diagnosed with diabetes mellitus, ill-defined disorder and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, glycosylated haemoglobin increased, hepatic function abnormal, hepatomegaly. Novorapid dosage: unknown. During the same period patient was treated with NOVOLIN N, RABEPRAZOLE, PRIMPERAN, HUMULIN. Patient was hospitalized. Patient recovered.
Novorapid Side Effects Report #4764867-X
Novorapid side effect was reported by a Physician from JAPAN on Aug 31, 2005. Male patient, 53 years of age, weighting 108.0 lb, was diagnosed with diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, decreased appetite, hepatic function abnormal, malaise. Novorapid dosage: unknown. During the same period patient was treated with GLYBURIDE, SIGMART, PANTOSIN, PANALDINE, AMANTADINE, ACTOS, BASEN. Patient recovered.
Novorapid Side Effects Report #5258311-6
Novorapid side effect was reported by a Physician from JAPAN on Feb 28, 2007. Male patient, weighting 99.21 lb, was diagnosed with diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: hepatic function abnormal. Novorapid dosage: unknown. During the same period patient was treated with ODRIC, LIPITOR. Patient recovered.
Novorapid Side Effects Report #5654621-9
Novorapid side effect was reported by a Physician from JAPAN on Feb 28, 2008. Male patient, weighting 110.2 lb, was diagnosed with diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: anti-insulin antibody positive, hepatic function abnormal, hypoglycaemia. Novorapid dosage: unknown. During the same period patient was treated with NOVORAPID CHU PENFILL, MELBIN, BASEN, AMARYL. Patient was hospitalized. Patient recovered.
Novorapid Side Effects Report #5670495-4
Novorapid side effect was reported by a Physician from JAPAN on Mar 10, 2008. Male patient, weighting 110.2 lb, was diagnosed with diabetes mellitus and was treated with Novorapid. After drug was administered, patient experienced the following side effects: anti-insulin antibody positive, hepatic function abnormal, hypoglycaemia. Novorapid dosage: unknown. During the same period patient was treated with NOVORAPID CHU PENFILL, MELBIN, BASEN, AMARYL. Patient was hospitalized. Patient recovered.